Along similar lines, Zeng et al. (2017), who examined the relationship between IL-6 in tissues and the risk of developing CRC, found a significant positive correlation between IL-6 levels and the stage of CRC [18]. This evidence concerns the gene IL6 and colorectal carcinoma.